Clinical Trial

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

Study acronym: STRATIFY
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Open label clinical randomized trial comparing three strategies for managing acute intermediate-high risk pulmonary embolism
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-09-11; most recent amendment 2024-11-14.
Status change: Recruiting → Active, Not Recruiting 2024-06-10
Trial Details
NCT Number NCT04088292
Lead Sponsor Rigshospitalet, Denmark
Collaborators: Herlev and Gentofte Hospital, University Hospital Bispebjerg and Frederiksberg, Hillerod Hospital, Denmark, Copenhagen University Hospital, Hvidovre
Conditions Pulmonary Embolism
Enrollment 210 participants
Start Date 2019-06-06
Primary Completion 2024-06-05 (estimated)
Study Completion 2024-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-15